Medtronic's diabetes spin-off MiniMed seeks $784M IPO at $7.86B valuation after six quarters of double-digit growth in booming CGM market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results